Nortech Systems Inc: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Aug 9, 2017 and accepted by EDGAR at Aug 9, 2017, 16:22 ET.
Management's discussion and analysis
As filed, 20,371 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview
We are a Maple Grove, Minnesota based full-service electronics manufacturing services (“EMS”) contract manufacturer of medical devices and systems wire and cable assemblies, printed circuit board assemblies and higher-level box builds for a wide range of industries. We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to our customers in the medical, aerospace and defense and industrial equipment markets. We maintain facilities in Minnesota, US; Monterrey, Mexico; and Suzhou, China. All of our facilities are certified to one or more of the ISO/AS standards, including 9001, AS9100 and 13485, with most having additional certifications based on the needs of the customers they serve.
In the second quarter of 2017 revenue grew by 4.1% to $30.1 million lead by our medical and global customers. Our gross margin improvement year over year is attributed to customer mix and our Suzhou, China operation moving into full production mode. Our operating profit in the second quarter was aided by a recovery of $0.3 million from a bad debt bankruptcy settlement in addition to the volume and mix in gross margin. Pretax income was negatively impacted by $0.2 million in debt extinguishment costs related to the change in our banking arrangement to Bank of America.
We had operating cash flows of $1.3 million and paid down debt by $0.9 million in the first six months of 2017. During the quarter our Board of Directors appointed a Chief Operating Officer (COO) to our executive team who will oversee all aspects of global manufacturing, engineering, sourcing and business development. Our COO has an international business background and extensive management experience in manufacturing, technology and finance with a focus on continuous improvement and automation.
2017 Second Quarter Highlights
The second quarter of 2017 revenue was $30.1 million, compared to revenue of $28.9 million in second quarter of 2016. Medical market revenue increased $1.8 million or 14.1% from prior year with our defense revenue down by $0.5 million or 11.2% and industrial revenue down $0.1 million or 0.9%. Heading into the third quarter, our backlog at June 30, 2017 is up 1.1% from the start of the quarter and 4.2% compared to the prior year.
Our second quarter 2017 gross margin of $3.4 million or 11.2% of sales was up $0.3 million and 40 basis points from the prior year primarily due to customer mix and our China operation now in full production mode compared to starting up costs in the prior year.
Operating profit for the second quarter of 2017 was $0.1 million as compared to loss of $0.1 million for the prior year’s second quarter. The $0.2 million increase was due to the higher gross margin and a bad debt recovery of $0.3 million from a bankruptcy settlement.
Net loss for the three months ended June 30, 2017 was $15,667 or $0.01 loss per basic and diluted common share compared to net loss for the three months ended June 30, 2016 of $0.2 million or $0.07 loss per basic and diluted common share. Net loss for the six months ended June 30, 2017 was $30,319 or $0.01 loss per basic and diluted common share compared to net loss for the six months ended June 30, 2016 of $0.1 million or $0.04 loss per basic and diluted common share. The current net loss for the three and six months ended June 30, 2017 was due to approximately $0.2 million for debt extinguishment costs. Excluding this item, we would have had net income for the three and six months ended June 30, 2017 of approximately $0.2 million and $0.1 million, respectively.
Results of Operations
The following table presents statements of operations data as percentages of total net sales for the periods indicated:
| Three Months Ended June 30, 2017 | 2016 | Six Months Ended June 30, 2017 | 2016 | |
|---|---|---|---|---|
| Net Sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of Goods Sold | 88.8 | 89.2 | 89.0 | 88.8 |
| Gross Profit | 11.2 | 10.8 | 11.0 | 11.2 |
| Selling Expenses | 4.4 | 4.5 | 4.3 | 4.5 |
| General and Administrative Expenses | 6.5 | 6.7 | 7.0 | 6.5 |
| Gain on Sale of Property and Equipment | 0.0 | 0.0 | (0.6) | 0.0 |
| Income (Loss) from Operations | 0.3 | (0.4) | 0.3 | 0.2 |
| Other Expenses | (1.0) | (0.4) | (0.8) | (0.5) |
| Loss Before Income Taxes | (0.7) | (0.8) | (0.5) | (0.3) |
| Income Tax Benefit | (0.7) | (0.2) | (0.4) | (0.1) |
| Net Loss | 0.0% | (0.6)% | (0.1)% | (0.2)% |
Net Sales
Net sales by our major EMS industry markets for the three and six month periods ended June 30, 2017 and 2016 were as follows:
| Three Months Ended June 30, | Six Months Ended June 30, | |
|---|---|---|
| 2017 2016% | 2017 2016% | |
| (in thousands) | $$ Change | $$ Change |
| Aerospace and Defense | 3,887 4,376 -11.2% | 7,238 8,396 -13.8% |
| Medical | 14,397 12,613 14.1% | 28,255 24,209 16.7% |
| Industrial | 11,850 11,956 -0.9% | 22,959 25,290 -9.2% |
| Total Sales | 30,134 28,945 4.1% | 58,452 57,895 1.0% |
Net sales were $30.1 million in the second quarter of 2017, as compared to $28.9 million in the second quarter of the prior year, an increase of $1.2 million or 4.1%. Net sales results were varied by markets, the medical market increased by $1.8 million or 14.1%. The industrial market sector was slightly down $0.1 million in the second quarter of 2017 as compared to the same quarter of 2016, primarily from lower demand levels from our transportation equipment customers. Net sales from the aerospace and defense markets decreased by 11.2% in the second quarter of 2017 as compared to the second quarter of 2016 due to lower customer demands.
Net sales were $58.5 million in the six months ended June 30, 2017, as compared to $57.9 million in the prior year, an increase of $0.6 million or 1.0%. Net sales results were varied by markets, the medical market increased by $4.0 million or 16.7%. The industrial market sector was down $2.3 million in the first six months of 2017 as compared to the same period of 2016, primarily from lower demand levels from our transportation equipment customers. Net sales from the aerospace and defense markets decreased $1.2 million or 13.8% in the first six months of 2017 as compared to 2016 due to lower customer demands.
Backlog
90 day backlog by our major EMS industry markets are as follows:
(in thousands)
| Backlog as of the Quarter Ended June 30, 2017 | March 31, 2017 | June 30, 2016 | |
|---|---|---|---|
| Aerospace and Defense | $4,252 | $4,122 | $4,791 |
| Medical | 12,282 | 11,917 | 11,428 |
| Industrial | 7,176 | 7,418 | 6,526 |
| Total Backlog | $23,710 | $23,457 | $22,745 |
Our 90-day order backlog as of June 30, 2017 was $23.7 million, a 1.1% increase from the beginning of the quarter and a 4.2% increase as compared to the prior year. Backlog for our medical customers has increased 7.5% over the prior year and 3.1% over the prior quarter. The aerospace and defense backlog increased 3.2% since the beginning of the quarter and decreased 11.2% from the prior year as past due orders were reduced significantly. Our industrial customers’ backlog decreased 3.3% since from the beginning of the quarter and increased 10.0% from the prior year, improving our position heading into the third quarter. Our backlog consists of firm purchase orders and we expect a major portion of the current 90 day backlog to be realized as revenue during the following quarter.
Our 90 day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next.
Gross Profit
Gross profit as a percent of net sales for the three months ended June 30, 2017 and 2016, was 11.2% and 10.8%, respectively. The increase in gross profit in the second quarter of 2017 as compared to the same period last year was primarily due to customer mix and our China operation now in full production mode compared to starting up costs in the prior year. Gross profit as a percentage of net sales for the six months ended June 30, 2017 and 2016 was 11.0% and 11.2%, respectively.
Selling Expense
Selling expense for the three months ended June 30, 2017 and 2016 was $1.3 million or 4.4% of sales and $1.3 million or 4.5% of sales, respectively. We will continue to fund business development to this level to support activities and marketing initiatives to maintain existing business and stimulate sales growth. Selling expense for the six months ended June 30, 2017 and 2016 was $2.5 million or 4.3% of sales and $2.6 million or 4.5% of sales, respectively.
General and Administrative Expense
General and administrative expenses for the three months ended June 30, 2017 and 2016, were $1.9 million or 6.5% of sales and $1.9 million or 6.7% of sales, respectively. The increase in professional service fees, investments in information systems resources and our new China operations were offset by a bad debt bankruptcy recovery settlement.
General and administrative expenses for the six months ended June 30, 2017 and 2016 were $4.1 million or 7.0% of sales and $3.8 million or 6.5% of sales, respectively. The increase in professional service fees, investments in information systems resources and our new China operations account for the majority of the increased spending.
Gain from Sale of Property and Equipment
Net gain from sale of property and equipment for the six months ended June 30, 2017 was $0.4 million from the sale of the Augusta building and building improvements (see Note 6). There was no gain from sale of property and equipment recorded in 2016.
Income from Operations
Second quarter 2017 income from operations was $0.1 million as compared to a loss of $0.1 million for the second quarter in 2016. The increase in income from operations of for the quarter was due to the higher gross margin and a bad debt recovery.
Income from operations for the first six months in 2017 was $0.2 million as compared to $0.1 million for the same comparable period in 2016. The increase in income from operations for the period was due to a gain on the sale of our Augusta facility and bad debt recovery partially offset by increased general and administrative expenses.
Income Taxes
The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three months ended June 30, 2017 and 2016 are as follows:
| Three Months Ended June 30, 2017 | 2016 | Six Months Ended June 30, 2017 | 2016 | |
|---|---|---|---|---|
| Statutory federal tax provision (benefit) | $(74,500) | $(89,000) | $(81,000) | $(55,000) |
| State income tax expense (benefit) | (6,900) | 13,000 | (500) | 16,000 |
| Income tax credits | (25,000) | (17,000) | (50,000) | (40,000) |
| Change in uncertain tax positions | 2,500 | — | 5,000 | — |
| Foreign tax benefit | (96,300) | — | (82,000) | — |
| Other | (5,400) | 24,000 | (1,500) | 36,000 |
| Income tax benefit | $(205,600) | $(69,000) | $(210,000) | $(43,000) |
Historically, the Company estimates the effective tax rate for the full fiscal year and records a quarterly income tax provision based on the anticipated rate and refines our estimates quarterly based on facts and circumstances including discrete events, by each jurisdiction. For the current quarter, the Company is utilizing an estimated year-to-date effective tax rate rather than the estimated annual rate approach as a result of changes in the forecast. Our effective tax rate for the three and six months ended June 30, 2017 was 92.9% and 87.4%, respectively. Our effective tax rate for the three and six months ended June 30, 2016 was 27.7% and 26.8%, respectively. The increase in our current year-to-date effective rate versus prior year is due mainly to the higher level of pretax book loss and the related increase in the foreign tax rate differential benefit.
Net Income (Loss)
Net loss for the three months ended June 30, 2017 was $15,667 or $0.01 loss per basic and diluted common share compared to net loss for the three months ended June 30, 2016 of $0.2 million or $0.07 loss per basic and diluted common share. Net loss for the six months ended June 30, 2017 was $30,319 or $0.01 loss per basic and diluted common share compared to net loss for the six months ended June 30, 2016 of $0.1 million or $0.04 loss per basic and diluted common share. The current net loss for the three and six months ended June 30, 2017 was due to approximately $0.2 million for debt extinguishment costs. Excluding this item, we would have had net income for the three and six months ended June 30, 2017 of approximately $0.2 million and $0.1 million, respectively.
Liquidity and Capital Resources
We had total cash of $0.5 million consisting of unrestricted cash of $0.2 million and restricted cash of $0.3 million.
Net cash provided in operating activities increased by $0.2 million to $1.3 million for the six months ended June 30, 2017 compared to $1.1 million for the six months ended June 30, 2016. Increases in accounts payable, through the extension of terms and conditions, and the reduction in our overall accounts receivable has positively impacted cash flows.
Net cash provided by investing activities of $0.2 million for the six months ended June 30, 2017, was generated from the proceeds of the sale of the Augusta building (see Note 6), offset by property and equipment purchases to support the business.
We have satisfied our liquidity needs over the past several years with cash flows generated from operations and a bank operating line of credit. We also have a real estate and equipment term loan. We have a credit agreement with Bank of America (BofA) which was entered into on June 15, 2017 and provides for a line of credit arrangement of $16.0 million that expires on June 15, 2022. The credit arrangement also has a $5.0 million real estate term note outstanding with a maturity date of June 15, 2022.
Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit and real estate term notes with BofA contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.
On June 30, 2017, we had outstanding advances of $6.6 million under the line of credit and unused availability of $7.4 million supported by our borrowing base compared to $5.7 million available on December 31, 2016. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $19.2 million and $19.2 million as of June 30, 2017 and December 31, 2016, respectively.
We met our credit agreement with BofA which requires us to maintain a minimum fixed charge coverage ratio of not less than 1.00 to 1.00.
Cash conversion cycle:
| Three Months Ended June 30, 2017 | 2016 | Six Months Ended June 30, 2017 | 2016 | |
|---|---|---|---|---|
| Days in trade accounts receivable | 54 | 52 | 52 | 52 |
| Days in inventory | 74 | 78 | 76 | 77 |
| Days in accounts payable | (53) | (47) | (52) | (46) |
| Cash conversion cycle | 75 | 83 | 76 | 83 |
We calculate days in accounts receivable as accounts receivable for the respective quarter and year-to-date period divided by annualized sales for the respective quarter and year-to-date period by day. We calculate days in inventory and accounts payable as each balance sheet line item for the respective quarter and year-to-date period divided by annualized cost of sales for the respective quarter and year-to-date period by day. We calculate cash conversion cycle as the sum of days in receivable and inventory less days in accounts payable. Items which may cause the cash conversion cycle in a particular period to differ include, but are not limited to, changes in business mix, changes in payment terms and the timing of revenue recognition and inventory purchases within the period. Days in accounts payable for the three and six months ended June 30, 2017 increased by six days compared to the three and months ended June 30, 2016, as a result of the timing of payments. Days in inventory for the three and six months ended June 30, 2017 improved by four days and one day, respectively compared to the three and months ended June 30, 2016. The improvements were partially offset by a slight increase in days in accounts receivable as a result of timing of collections.
Off-Balance Sheet Arrangements
We have not engaged in any off-balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.
Critical Accounting Policies and Estimates
Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2016. There have been no significant changes in these critical accounting policies since December 31, 2016. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.
Forward-Looking Statements
Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:
- Volatility in the marketplace which may affect market supply and demand for our products;
- Increased competition;
- Changes in the reliability and efficiency of operating facilities or those of third parties;
- Risks related to availability of labor;
- Increase in certain raw material costs such as copper;
- Commodity and energy cost instability;
- Dependence on certain customers;
- Possible customer cancellations of orders, impact of financial difficulty of customers and other factors that could cause losses relating to customer orders;
- General economic, financial and business conditions that could affect our financial condition and results of operations; and
- Availability of raw material components.
The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.
Please refer to forward-looking statements and risks as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
Controls and procedures
As filed, 1,458 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $26.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $52.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-04-01 to 2017-06-30 | $3.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2017-01-01 to 2017-06-30 | $6.5m | us-gaap:GrossProfit |
| Operating income | 3 months2017-04-01 to 2017-06-30 | $94.7k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | $215.1k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-04-01 to 2017-06-30 | $141.5k | us-gaap:InterestExpense |
| Interest expense | 6 months2017-01-01 to 2017-06-30 | $281.0k | us-gaap:InterestExpense |
| Income tax | 3 months2017-04-01 to 2017-06-30 | −$206.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | −$210.4k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | −$15.7k | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | −$30.3k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 2,747,831 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 2,747,831 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-01-01 to 2017-06-30 | $1.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $358.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2017-06-30 | $190.7k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $40.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $55.9m | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $21.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $33.6m | us-gaap:Liabilities |
| Long-term debt | At period end2017-06-30 | $4.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-06-30 | $1.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-06-30 | $22.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-17-050719. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.